“In the diagnosis of lung cancer, the possibility of performing an NGS test is essential, because it allows to acquire the greatest amount of information about genomic profiling without running the risk of running out of biological sample available”. Thus Renato Franco, coordinator of the Italian study group of pulmonary pleural pathology, explained the advantages of the new NGS (Next Generation Sequencing) tests during a webinar promoted by The European House Ambrosetti, with the non-conditioning contribution of Amgen.
#Molecular #oncology #Franco #Fundamental #NGS #tests #genomic #profiling